Transforming growth factor-beta-induced protein secreted by peritoneal cells increases the metastatic potential of ovarian cancer cells.
about
Adhesion molecules in peritoneal dissemination: function, prognostic relevance and therapeutic optionsMacrophage TGF-β1 and the Proapoptotic Extracellular Matrix Protein BIGH3 Induce Renal Cell Apoptosis in Prediabetic and Diabetic ConditionsEpithelial ovarian cancer - more data, more questions?Keratin 5 overexpression is associated with serous ovarian cancer recurrence and chemotherapy resistance.Transforming growth factor-β-induced protein (TGFBI) suppresses mesothelioma progression through the Akt/mTOR pathwayThe role of TGFBI in mesothelioma and breast cancer: association with tumor suppression.Role of versican, hyaluronan and CD44 in ovarian cancer metastasis.Chemotherapy-induced hyaluronan production: a novel chemoresistance mechanism in ovarian cancer.βig-h3 promotes human osteosarcoma cells metastasis by interacting with integrin α2β1 and activating PI3K signaling pathway.TGFBI expression reduces in vitro and in vivo metastatic potential of lung and breast tumor cells.Transketolase is upregulated in metastatic peritoneal implants and promotes ovarian cancer cell proliferation.Proteomic identification of betaig-h3 as a lysophosphatidic acid-induced secreted protein of human mesenchymal stem cells: paracrine activation of A549 lung adenocarcinoma cells by betaig-h3.Lymph node metastasis of primary endometrial cancers: Associated proteins revealed by MALDI imaging.The role of novel and known extracellular matrix and adhesion molecules in the homeostatic and regenerative bone marrow microenvironmentChick chorioallantoic membrane (CAM) assay as an in vivo model to study the effect of newly identified molecules on ovarian cancer invasion and metastasis.Transforming growth Factor-Beta-Induced Protein (TGFBI)/(βig-H3): a matrix protein with dual functions in ovarian cancer.Differential secretome analysis reveals CST6 as a suppressor of breast cancer bone metastasisß3 integrin modulates transforming growth factor beta induced (TGFBI) function and paclitaxel response in ovarian cancer cells.Release of TGFβig-h3 by gastric myofibroblasts slows tumor growth and is decreased with cancer progression.GPER1-mediated IGFBP-1 induction modulates IGF-1-dependent signaling in tamoxifen-treated breast cancer cells.Human epithelial-type ovarian tumour marker beta-2-microglobulin is regulated by the TGF-β signaling pathway.Comparative proteomic analysis of normal and collagen IX null mouse cartilage reveals altered extracellular matrix composition and novel components of the collagen IX interactome.Annexin A2 is regulated by ovarian cancer-peritoneal cell interactions and promotes metastasis.TGFBI expression is an independent predictor of survival in adjuvant-treated lung squamous cell carcinoma patients.The role of annexin A2 in tumorigenesis and cancer progressionProteomic profiling of the cancer cell secretome: informing clinical research.Growth Hormone Induces Transforming Growth Factor-Beta-Induced Protein in Podocytes: Implications for Podocyte Depletion and Proteinuria.Bigh3 silencing increases retinoblastoma tumor growth in the murine SV40-TAg-Rb model.Androgen receptor protein levels are significantly reduced in serous ovarian carcinomas compared with benign or borderline disease but are not altered by cancer stage or metastatic progression.The role of TGFBI (βig-H3) in gastrointestinal tract tumorigenesis.TGFBI Expressed by Bone Marrow Niche Cells and Hematopoietic Stem and Progenitor Cells Regulates Hematopoiesis
P2860
Q26748666-3B22F24B-452D-4C99-AE0C-B2B245777B6DQ28817901-AEE63D37-C5B8-46CE-B29C-495CCE2CAADBQ30869183-F172644F-4D17-4842-86A5-B3182B337DEDQ33566693-29F8A7A1-0238-473D-B112-EF19790FE7B9Q33878064-0F3054B6-53ED-4EC6-8357-FE906931B165Q34303247-5FB0095F-814E-48A5-946B-B72772DC03DCQ34874835-6D1E8F53-C526-4B22-AD6F-99AD04113886Q35017209-FA44995F-EE1F-4519-A14B-C97592EE0A07Q35111094-811FC03D-904D-40F7-B954-8303787F6779Q35196910-FBF7F837-59EB-4AEF-9B3C-7C98BB3904B3Q35610292-5EB97A5A-0E25-4503-86FB-5CAAA356A827Q35751677-DFDCF968-7499-46BD-BA3B-08F86691BCD2Q35984477-6E8A90FA-18FC-4B60-95B7-38124D9D523FQ36124907-2749626D-6527-4214-B7A5-AC58A04337CEQ36202406-2CFFEBAD-5F8B-4810-B7C1-D72D620CD53EQ36202508-BCF5E905-FC37-4810-A648-BF7DE3C89861Q36210416-A371596B-1688-4C15-8522-D8E72BB7B1B5Q36235795-4D4E054E-4E25-4B24-B356-AFE7D9774158Q36402018-68B448C5-E61A-472E-A51A-61DBAEB34C4EQ36547331-19E71A66-996B-4B4E-9913-C88DEBC6CD5CQ36691897-D80EFB49-BC9F-425E-B911-4975851C3D45Q36832626-E190D190-2853-4449-ABA1-350814C6B486Q37207658-E5BC0AB2-C2C0-4D8F-9446-3A32B451DE14Q37650665-A6B9F4DF-7169-45E4-8C5F-62B317F6D32CQ38366258-E7ADB6AA-FEAC-47FA-BDD3-E2497938B0B4Q38659528-432BAD5F-9725-4766-A6ED-6FCC716E353EQ38903408-97B776A2-CF3E-4459-9182-2A24EB0EBD6AQ39014286-45E61D52-BE0A-4C1B-86F2-F21118ED8080Q39188061-F75B4544-1295-416D-BF93-CAE97DCC9F88Q40786475-7994E50B-E4D5-47C8-B6C4-296F244D818FQ58709813-8AAF6265-8AD4-4596-8836-51298C8218D8
P2860
Transforming growth factor-beta-induced protein secreted by peritoneal cells increases the metastatic potential of ovarian cancer cells.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
2010年學術文章
@zh
2010年學術文章
@zh-hant
name
Transforming growth factor-bet ...... ntial of ovarian cancer cells.
@en
Transforming growth factor-bet ...... ntial of ovarian cancer cells.
@nl
type
label
Transforming growth factor-bet ...... ntial of ovarian cancer cells.
@en
Transforming growth factor-bet ...... ntial of ovarian cancer cells.
@nl
prefLabel
Transforming growth factor-bet ...... ntial of ovarian cancer cells.
@en
Transforming growth factor-bet ...... ntial of ovarian cancer cells.
@nl
P2860
P50
P356
P1476
Transforming growth factor-bet ...... ential of ovarian cancer cells
@en
P2093
Martin K Oehler
Raymond J Rodgers
P2860
P304
P356
10.1002/IJC.25494
P577
2010-06-02T00:00:00Z